Hepatocytes in liver injury: Victim, bystander, or accomplice in progressive fibrosis?-Reference-Cited by-同舟云学术

Hepatocytes in liver injury: Victim, bystander, or accomplice in progressive fibrosis?

Published:2015-11-24 Issue:12 Volume:30 Page:1696-1704
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:Journal of Gastroenterology and Hepatology

Author:

Tu Thomas¹²,Calabro Sarah R.¹²,Lee Aimei¹²,Maczurek Annette E.¹²,Budzinska Magdalena A.¹²,Warner Fiona J.¹²,McLennan Susan V.²³,Shackel Nicholas A.¹²⁴

Affiliation:

1. Liver Injury and Cancer; Centenary Institute; Sydney New South Wales Australia

2. Sydney Medical School; The University of Sydney; Sydney New South Wales Australia

3. Department of Endocrinology; Royal Prince Alfred Hospital; Sydney New South Wales Australia

4. A. W. Morrow Gastroenterology and Liver Centre; Royal Prince Alfred Hospital; Sydney New South Wales Australia

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jgh.13065/fullpdf

Reference75 articles.

1. Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis;Kisseleva;Proc. Natl. Acad. Sci. U. S. A.,2012

2. A good model of hepatic failure after excessive hepatectomy in mice;Makino;J. Surg. Res.,2005

3. The ratio of ELR+ to ELR− CXC chemokines affects the lung and liver injury following hepatic ischemia/reperfusion in the rat;Colletti;Hepatology,2000

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Developing an RNA Signature for Radiation Injury Using a Human Liver-on-a-Chip Model;Radiation Research;2024-08-02

2. Targeting chronic liver diseases: Molecular markers, drug delivery strategies and future perspectives;International Journal of Pharmaceutics;2024-07

3. Dibutyl phthalate (DBP) promotes Epithelial-Mesenchymal Transition (EMT) to aggravate liver fibrosis into cirrhosis and portal hypertension (PHT) via ROS/TGF-β1/Snail-1 signalling pathway in adult rats;Ecotoxicology and Environmental Safety;2024-04

4. The novel mechanism facilitating chronic hepatitis B infection: immunometabolism and epigenetic modification reprogramming;Frontiers in Immunology;2024-01-15

5. 3D microscaffolds with triple-marker sensitive nanoprobes for studying fatty liver disease in vitro;Nanoscale;2024